Placebo for osimertinib (AZD9291) pemetrexed cisplatin or carboplatin clinical trials

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

This study looks at a new way to treat a type of lung cancer that has grown despite earlier treatment. It combines standard chemotherapy with a drug called osimertinib, or with a dummy pill, to see which works better and is safer.